Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Letters15 April 2008Successful Treatment of Fulminant Clostridium difficile Infection with Fecal BacteriotherapyDavid M. You, MD, M. Alaric Franzos, MD, and Robert P. Holman, MDDavid M. You, MDFrom National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205., M. Alaric Franzos, MDFrom National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205., and Robert P. Holman, MDFrom National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-148-8-200804150-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: A subset of patients with Clostridium difficile–associated diarrhea will develop fulminant, life-threatening C. difficile infection that is refractory to medical therapy. Surgical options for fulminant disease are associated with high mortality rates. We describe a patient with fulminant C. difficile infection successfully treated with donor stool by retention enema.Objective: To describe a successful case of using fecal bacteriotherapy to treat life-threatening, fulminant C. difficile enterocolitis.Case Report: A 69-year-old man was admitted to the hospital after undergoing radical prostatectomy. The patient was given perioperative, intravenous cefazolin. On postoperative day 2, the patient developed an ileus and oliguric renal ...References1. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363-72. [PMID: 11882758] CrossrefMedlineGoogle Scholar2. Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8:149-54. [PMID: 16412077] CrossrefMedlineGoogle Scholar3. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580-5. [PMID: 12594638] CrossrefMedlineGoogle Scholar4. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol. 2000;95:3283-5. [PMID: 11095355] MedlineGoogle Scholar5. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet. 1989;1:1156-60. [PMID: 2566734] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From National Naval Medical Center, Bethesda, MD 20889, and Virginia Hospital Center, Arlington, VA 22205.Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Department of the Navy, U.S. Department of Defense, or the U.S. government.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByFecal Microbial Transplantation in Critically Ill Patients—Structured Review and PerspectivesExploring Human Bacterial Diversity Toward Prevention of Infectious Disease and Health PromotionTrasplante de microbiota fecal en el tratamiento de colitis grave complicada por C. difficile en un paciente con síndrome de inmunodeficiencia adquiridaFecal microbiota transplantation for severe complicated C. difficile colitis in a patient with acquired immunodeficiency syndromeSafety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic reviewResearch Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration SystemControl of Clostridium difficile Infection by Defined Microbial CommunitiesIntestinal-Based Diseases and Peripheral Infection Risk Associated with Gut Dysbiosis: Therapeutic use of Pre- and Probiotics and Fecal Microbiota TransplantationControl of Clostridium difficile Infection by Defined Microbial CommunitiesFecal microbiota transplant in severe and severe-complicated Clostridium difficile : A promising treatment approachCurrent challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantationFMT in Clostridium difficile and Other Potential UsesFecal microbiota transplant in patients with Clostridium difficile infectionFecal Microbiota TransplantElevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adultsEpidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel DiseaseLong-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile InfectionFe
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however a few case reports suggest that it may be safe and effective even in critically ill patients18–21.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [18]
Citations
Cites
Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
The outcome of surgery in fulminant Clostridium difficile colitis
Koss, K., Clark, M. A., Sanders, D. S. A., Morton, D., Keighley, M. R. B., & Goh, J. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2005.00876.x · Cited by 184
Persky, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02095-5 · Cited by 179
Research works printed but not linked: 1
- Persky SE, 2000, Am J Gastroenterol, 95, 3283
Cited by
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Unravelling the effects of the environment and host genotype on the gut microbiome
Spor, A., Koren, O., & Ley, R. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2540 · Cited by 1,509
Ursell, L. K., Metcalf, J. L., Parfrey, L. W., & Knight, R. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00493.x · Cited by 1,255
“One fascinating hint that the microbiota may be more plastic than imagined is the recent success of treatment of persistent Clostridum difficile infections via stool transplant, which has been successful in a number of studies[66-72], and in general the depauperate gut community produced during the C.”
BackgroundGough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
“Where treatment before IMT was classified as ‘‘other,’’ all failures occurred in patients who received vancomycin and omeprazole (a proton pump inhibitor) before IMT [48, 55, 58].”
Background
Metadata
- Authors
- You, D. M., Franzos, M. A., & Holman, R. P.
- Affiliations
- Walter Reed National Military Medical Center (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2008-04-15
- Volume
- 148
- Issue
- 8
- Pages
- 632-633
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2024189494
- Cited by
- 99
- References
- 5
- Citations by year
- 2023: 1 · 2021: 2 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 14 · 2014: 13 · 2013: 11 · 2012: 16
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Clostridium difficile infection, refractory diarrhea, radical prostatectomy, cefazolin, oliguric renal failure, ileus, antibiotic-associated diarrhea, fecal microbiota transplantation, postoperative mortality
- MeSH terms
- Aged, Diarrhea, Enema, Enterocolitis, Pseudomembranous, Feces, Humans, Male, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy. https://app.cochat.ai/papers/10.7326/0003-4819-148-8-200804150-00024
- The paper
- You, D. M., Franzos, M. A., & Holman, R. P. (2008). Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-8-200804150-00024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.